chr17-50167819-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000023.4(SGCA):​c.312+83C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.837 in 1,552,088 control chromosomes in the GnomAD database, including 544,610 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.84 ( 53165 hom., cov: 32)
Exomes 𝑓: 0.84 ( 491445 hom. )

Consequence

SGCA
NM_000023.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.610

Publications

14 publications found
Variant links:
Genes affected
SGCA (HGNC:10805): (sarcoglycan alpha) This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
SGCA Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 17-50167819-C-T is Benign according to our data. Variant chr17-50167819-C-T is described in ClinVar as Benign. ClinVar VariationId is 669840.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.933 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000023.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCA
NM_000023.4
MANE Select
c.312+83C>T
intron
N/ANP_000014.1
SGCA
NM_001135697.3
c.312+83C>T
intron
N/ANP_001129169.1
SGCA
NR_135553.2
n.348+83C>T
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCA
ENST00000262018.8
TSL:1 MANE Select
c.312+83C>T
intron
N/AENSP00000262018.3
SGCA
ENST00000344627.10
TSL:1
c.312+83C>T
intron
N/AENSP00000345522.6
SGCA
ENST00000682109.1
c.192+83C>T
intron
N/AENSP00000508041.1

Frequencies

GnomAD3 genomes
AF:
0.836
AC:
127071
AN:
152060
Hom.:
53132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.827
Gnomad AMI
AF:
0.786
Gnomad AMR
AF:
0.805
Gnomad ASJ
AF:
0.854
Gnomad EAS
AF:
0.956
Gnomad SAS
AF:
0.859
Gnomad FIN
AF:
0.849
Gnomad MID
AF:
0.858
Gnomad NFE
AF:
0.834
Gnomad OTH
AF:
0.862
GnomAD4 exome
AF:
0.837
AC:
1172235
AN:
1399910
Hom.:
491445
Cov.:
23
AF XY:
0.838
AC XY:
585395
AN XY:
698652
show subpopulations
African (AFR)
AF:
0.821
AC:
26296
AN:
32036
American (AMR)
AF:
0.781
AC:
34622
AN:
44348
Ashkenazi Jewish (ASJ)
AF:
0.862
AC:
22038
AN:
25552
East Asian (EAS)
AF:
0.955
AC:
37522
AN:
39298
South Asian (SAS)
AF:
0.864
AC:
73443
AN:
85026
European-Finnish (FIN)
AF:
0.840
AC:
44605
AN:
53116
Middle Eastern (MID)
AF:
0.827
AC:
4654
AN:
5628
European-Non Finnish (NFE)
AF:
0.833
AC:
879863
AN:
1056576
Other (OTH)
AF:
0.843
AC:
49192
AN:
58330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
9955
19909
29864
39818
49773
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19738
39476
59214
78952
98690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.836
AC:
127163
AN:
152178
Hom.:
53165
Cov.:
32
AF XY:
0.836
AC XY:
62198
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.827
AC:
34322
AN:
41514
American (AMR)
AF:
0.805
AC:
12318
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.854
AC:
2964
AN:
3470
East Asian (EAS)
AF:
0.956
AC:
4942
AN:
5172
South Asian (SAS)
AF:
0.859
AC:
4142
AN:
4824
European-Finnish (FIN)
AF:
0.849
AC:
8999
AN:
10598
Middle Eastern (MID)
AF:
0.864
AC:
254
AN:
294
European-Non Finnish (NFE)
AF:
0.834
AC:
56692
AN:
67990
Other (OTH)
AF:
0.860
AC:
1815
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1082
2164
3247
4329
5411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.834
Hom.:
58706
Bravo
AF:
0.832
Asia WGS
AF:
0.897
AC:
3118
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal recessive limb-girdle muscular dystrophy type 2D Benign:1
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.22
DANN
Benign
0.38
PhyloP100
-0.61
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2696297; hg19: chr17-48245180; API